When the use of prophylactic granulocyte-colony stimulating factor (G-CSF) to reduce febrile neutropenia (FN) was decreased in patients receiving chemotherapy for breast cancer, it led to a more than ...
Post-CAR T infection prophylaxis should follow European Hematology Association/European Society for Blood and Marrow ...
A study published in the Journal of Cannabis Research examined the effect of granulocyte colony-stimulating factor (G-CSF) on brain recovery following trau | Cannabis Sciences ...
Adults with severe alcoholic hepatitis had better odds of surviving to 90 days if they received prednisolone with granulocyte-colony stimulating factor (G-CSF), according to a three-arm randomized ...
- APHEXDA is the first innovation in stem cell mobilization for multiple myeloma to be approved in the U.S. in a decade - - One dosage of APHEXDA plus filgrastim enabled a majority of patients to ...
Erratum: ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma Treatment Intensification With Either ...
WASHINGTON — Adding granulocyte-colony stimulating factor (G-CSF) to steroid therapy can improve 90-day survival for patients with severe alcoholic hepatitis (SAH), researchers from India reported.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback